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Abstract: Background: During the COVID-19 pandemic, the virus evolved, and we therefore aimed
to provide an insight into which genetic variants were enriched, and how they spread in Sweden.
Methods: We analyzed 348 Swedish SARS-CoV-2 sequences freely available from GISAID obtained
from 7 February 2020 until 14 May 2020. Results: We identified 14 variant sites ≥5% frequency in the
population. Among those sites, the D936Y substitution in the viral Spike protein was under positive
selection. The variant sites can distinguish 11 mutational profiles in Sweden. Nine of the profiles
appeared in Stockholm in March 2020. Mutational profiles 3 (B.1.1) and 6 (B.1), which contain the
D936Y mutation, became the predominant profiles over time, spreading from Stockholm to other
Swedish regions during April and the beginning of May. Furthermore, Bayesian phylogenetic analysis
indicated that SARS-CoV-2 could have emerged in Sweden on 27 December 2019, and community
transmission started on February 1st with an evolutionary rate of 1.5425 × 10−3 substitutions per
year. Conclusions: Our study provides novel knowledge on the spatio-temporal dynamics of
Swedish SARS-CoV-2 variants during the early pandemic. Characterization of these viral variants
can provide precious insights on viral pathogenesis and can be valuable for diagnostic and drug
development approaches.
Keywords: SARS-CoV-2; evolution; mutation; spike protein
1. Introduction
A new pandemic, coronavirus disease 2019 (COVID-19), emerged in 2019 and was caused by a
new coronavirus, designated as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) [1–3].
SARS-CoV-2 is a positive-sense single-stranded RNA virus with a genome of about 30 kb that encodes
four structural proteins: the spike (S) protein, the envelope (E) protein, the matrix (M) protein, and
the nucleocapsid (N) protein; together with 8 accessory proteins and 16 non-structural proteins [4],
including the RNA-dependent RNA polymerase (RdRp) and the nsP14 with exonuclease activity and
proof-reading function [5]. Due to its high transmissibility and lack of pre-existing immunity against
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this novel virus in the human population, the rapid spread of SARS-CoV-2 is currently a huge threat to
public health and global economies.
The first case of COVID-19 in Sweden was reported on 31 January 2020 from a woman returning
from Wuhan to Jönköping. Soon after that, several introductions of COVID-19 cases were reported
and all were travel-related cases from Italy and Iran. The community transmission of COVID-19 was
thought to start in late February, especially in the Stockholm, Sörmland, Uppsala, Västra Götaland,
Örebro, and Östergötland regions. During the early pandemic (until 14 May), a total of 29,739 COVID-19
cases and 3834 deaths had been confirmed in Sweden [6].
To prevent the spread of SARS-CoV-2, many countries adopted strict non-pharmacological
interventions (NPIs) such as lockdowns, travel restrictions, and widespread business and school
closures to stop the transmission [7]. However, in response to the pandemic, Sweden took a unique
strategy where less strict NPIs were implemented. Instead, social recommendations were advised,
with the aim to slow down the spread of the virus and protect the risk group at the same time [8].
This unique strategy was meant to slow down the viral transmission in the population, but as compared
to more strict strategies, resulted in a higher probability of a slow but continuous evolution of the
virus. The high level of transmission provided us with an opportunity to investigate the evolutionary
profiling of Swedish SARS-CoV-2 over time.
This descriptive study is based on Swedish SARS-CoV-2 sequences that are freely available from
GISAID [9], where we compared how these strains diverged from the Wuhan prototype of SARS-CoV-2.
The study traced the dynamic mutational profiles of SARS-CoV-2 in Sweden and calculated the
time points when community transmission for these mutational profiles likely started. These viral
characteristics help us to understand how SARS-CoV-2 spread under the current Swedish mandates
against COVID-19 and the evolutionary traits it acquired within this time-frame.
2. Materials and Methods
2.1. Data Sets
The multiple alignment sequences and metadata including the sequence information, locations, and
collection date were downloaded from GISAID (https://www.gisaid.org/) on 9 June 2020. The Swedish
data was pulled out from the global dataset that contains 38,139 sequences. These 354 sequences
were originally sequenced by the Swedish Public Health Agency (FHM) and Centre for Translation
Microbiome Research (CTMR) at the Karolinska Institutet. Six sequences were excluded due to lack of
information on sampling date. The remaining 348 Swedish sequences and metadata were included into
the downstream analysis. Together with the reference sequence (NC, 045512), a total of 349 sequences
were realigned by using MAFFT with default settings, followed by manual refinement using Geneious
prime (https://www.geneious.com/prime/) [10]. The metadata (Table S1) was imported into R studio
for data visualization [11].
2.2. Mutation Sites in Swedish SARS-CoV-2 Sequences
The sequence dataset (348 Swedish SARS-CoV-2 sequences) and the reference sequence (Severe
acute respiratory syndrome coronavirus 2 Wuhan-Hu-1, GenBank accession number. NC, 045512) [5]
were imported into Geneious prime and the alignment was searched for variants/SNPs. A minimum
variant frequency of 0.05 was used as the cut-off with the default settings for p-value testing, which is
recommended by Geneious prime and in other genetic population studies [12,13]. The variant
frequency, locations, mutation type, and the nature of amino acid (aa) mutations in the population of
Swedish SASR-CoV-2 were analyzed.
2.3. Recombination Analysis and Selection Pressure
Potential recombination events were investigated using RDP3 [14]. The selection pressure for each
gene and branches were analysed using the following methods: MEME (Mixed Evolutionary Model of
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Evolution), FEL (Fixed Impact Probability), FUBAR (Fast Unconstrained Bayesian AppRoximation),
and aBSREL (adaptive branch-site REL test for episodic diversification) implemented in Datamonkey
(https://www.datamonkey.org) [15].
2.4. Evolutionary Dynamics Analysis of Mutational Profiles
A mutational profile for each sequence was created from all the variants detected with≥0.05 cut-off,
where all variants/mutations were concatenated together to make a mutational profile. Within our
sequence data-set, we observed 11 different mutational profiles (Table S1). Data was imported into R
studio for visualization using the packages ggplot2 and ggmuller to obtain a Muller plot of the Swedish
variants and the longitudinal cumulative mutational profile frequency [11]. Further data visualization
of the metadata of mutational profiles 3 and 6 was done by importing the data into Spyder using the
python packages matplotlib, numpy, and seaborn (https://www.python.org/download/releases/3.0/).
2.5. Phylogenetic Inference
RAxML was used to reconstruct the phylogenetic relationship of Swedish SARS-CoV-2 and the
other variants globally [16]. To reconstruct the evolutionary history of the Swedish SARS-CoV-2,
Bayesian phylogenetic trees of the complete sequences were constructed by employing BEAST v1.8.4.
Bayesian analysis consisted at least 50 million Bayesian Monte Carlo Markov chain (MCMC) generations
sampling every 5000 generations. The run was continued until convergence was obtained (average
deviation, <0.01) and with a 25% burn-in. To further infer the evolutionary rates and the most recent
common ancestor (tMRCA) of the mutational profiles, we first employed TempEst to test if the dataset
had a clocklike structure [17]. A regression of root-to-tip genetic distances of the dataset (348 Swedish
sequences and one from Wuhan) against date of sampling showed a clocklike structure (correlation
coefficient, 0.4736). Consequently, we used 6 different combinations of demographic and molecular
clock models and ran 50 million Bayesian MCMC generations sampling every 5000 generations,
implemented in BEAST v1.8.4 (Table S2). Model comparison was performed by a marginal-likelihood
estimator in two approaches, path sampling (PS) and stepping-stone sampling (SS); and selected
strict clock and exponential population as a better model for data analysis, with the log Bayesian
factor (BF) value over at least 25. In all analyses, the prototype (GenBank accession number NC,
045512), was used to root the tree. All computations were run using the CIPRES computational cluster
(http://www.phylo.org/index.php/). Finally, trees and sequence ID with the information of mutational
profiles were viewed and edited using FigTree v1.4.2 (http://tree.bio.ed.ac.uk/software/figtree/).
3. Results
3.1. Sequence Collection Overview
Our dataset (Table S1) comprises Swedish SARS-CoV-2 sequences from samples obtained between
7 February 2020 and 14 May 2020 (the first 98 days of the pandemic in Sweden). The age distribution
of the study consisted of 60 sequences obtained from COVID-19 patients that were ≥60 years old, 281
sequences obtained from COVID-19 patients ≤59 years old, and 7 with unknown age. There was
a slight gender bias of 179 sequences from men, 164 from women, and 5 with undisclosed gender
metadata. The sequences included in this study were from 18 different geographical locations across
Sweden, with the largest number of 149 sequences obtained from Stockholm, the capital of Sweden.
There were no individual sites identified as episodic positive/diversifying selection by MEME,
FEL, and aBSREL. However, the FUBAR test showed that four sites (L3606F and G392D on ORF1ab,
D936Y on S protein, T205I on N protein) were under episodic positive/diversifying selection with
posterior probability ≥ 0.95 and log BF ≥ 25. There were no recombination events observed.
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3.2. Divergence of SARS-CoV-2 in Sweden as Compared to the Prototype Sequence from Wuhan, China
We used a 5% minimum frequency as an arbitrary cut-off for searching the variants for the Swedish
SARS-CoV-2 variants. Table 1 shows all 14 mutational sites and their frequencies observed in the
dataset. From these 14 mutational sites, 2 were synonymous, 11 were non- synonymous, and 1 occurred
in a non-coding region. Seven out of the 11 non-synonymous mutations also conferred functional
modification to coding amino acid group, such as a negatively charged R group to a non-polar aliphatic
R group. The main mutational driving force seems to be transitional single nucleotide mutations,
with C→ T being the most prevalent. This could be a result of c-deamination, which is ubiquitous
in nature.
3.3. Mutational Profiles of Swedish SARS-CoV-2
In Sweden, a total of 11 mutational profiles (MPs) were circulating during the early pandemic
(Table 2). Mutations C241T, C3037T, C14408T, and A23403G (MP4) provided the basis for the other MPs
patterns; meanwhile, mutations G28881A, G28882A, and G28883C appeared together. Combination of
these two mutation patterns constituted MP3. The basis, together with mutations C1059T, G24368T,
and G25563T, constituted MP6. Different MPs or mutational combinations might be beneficial for
viral evolution.
From Figure 1, we can observe the introduction of SARS-CoV-2 virus into Sweden from
international sources with occasional re-introductions. As expected, the very early mutational
profile (MP1) constituted travel-associated cases, which were the main Swedish COVID-19 cases in
February. From the beginning of March, local transmission was the main driver for SARS-CoV-2 in
Sweden, i.e., 10 other MPs in addition to MP1 had emerged in the Swedish population. A Muller
plot depicts the mutational profile dynamics during these 98 days (Figure 1). MP 3 and MP 6 were
established as the dominant mutational profiles over our study time-period. On our last time-point,
MP3 was most prevalent in the dataset.Viruses 2020, 12, x FOR PEER REVIEW 7 of 15 
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Table 1. Observed mutations and the frequency.
Site (NC, 045512) Ref (NC, 045512) Variant Change Wild TypeFrequency (%)
Variant
Frequency (%) aa Change Type Region Amino Acid Property Change
241 C T 5.2 94.8 transition 5′UTR gene
1059 C T 73.6 26.4 T265I transition ORF1ab/nsp2 Polar, uncharged R group toNon-polar aliphatic R group
3037 C T 5.7 94.3 F924F transition ORF1ab/nsp3
12790 A G 94.8 5.2 T4175T transition ORF1ab/nsp9
13568 C T 94.8 5.2 A43V transition RNA-dependentRNA polymerase Both are non-polar aliphatic R groups
14408 C T 6.0 94.0 P323L transition RNA-dependentRNA polymerase
Polar, uncharged R group to
Non-polar aliphatic R group
22583 G A 94.8 5.2 V341I transition S Both are non-polar aliphatic R groups
23403 A G 5.2 94.8 D614G transition S Negatively charged R group toNon-polar aliphatic R group
24368 G T 82.8 17.2 D936Y transversion S Negatively charged R group to Polaraliphatic R group
25563 G T 72.2 27.8 Q57H transversion ORF3a Negatively charged R group toPositively charged R group
27046 C T 88.0 12.0 T175M transition M Polar, uncharged R group toNon-polar aliphatic R group
28881 G A 59.9 40.1 R203K transition N Both are positive R groups
28882 G A 59.9 40.1 R203K transition N Both are positive R groups
28883 G C 59.9 40.1 G204R transversion N Non-polar aliphatic R groups toPositively charged R group
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Table 2. Mutational profiles observed in Swedish sequences.
Profiles PANGOLIN Lineage GISAID Lineage Frequency (%) Mutational Profiling
Mutational Profile 1 B O 4.89 WT
B.4 O WT
B L WT
B.3 L WT
B.3 O WT
B.2.1 V WT
A S WT
Mutational Profile 2 B.1.1 GR 12.1 241C > T, 3037C > T, 14408C > T, 23403A > G, 27046C > T, 28881G > A,28882G > A, 28883G > C
Mutational profile 3 B.1.1 GR 27.9 241C > T, 3037C > T, 14408C > T, 23403A > G, 28881G > A, 28882G > A,28883G > C
B.1.1.1 GR 241C > T, 3037C > T, 14408C > T, 23403A > G, 28881G > A, 28882G > A,28883G > C
Mutational profile 4 B.1 G 15.5 241C > T, 3037C > T, 14408C > T, 23403A > G
B.1.5 G 241C > T, 3037C > T, 14408C > T, 23403A > G
B.1.5.3 G 241C > T, 3037C > T, 14408C > T, 23403A > G
Mutational Profile 5 B.1 G 6.03 241C > T, 3037C > T, 14408C > T, 22583G > A, 23403A > G
Mutational Profile, 6 B.1 GH 17.2 241C > T, 1059C > T, 3037C > T, 14408C > T, 23403A > G, 24368G > T,25563G > T
Mutational Profile 7 B.1.32 G 5.17 241C > T, 3037C > T, 12790A > G, 14408C > T, 14408C > T, 23403A > G
Mutational Profile 8 B.1 GH 1.43 241C > T, 3037C > T, 14408C > T, 23403A > G, 25563G > T
Mutational Profile, 8 B.1.36 GH 241C > T, 3037C > T, 14408C > T, 23403A > G, 25563G > T
Mutational Profile 9 B.1 GH 9.20 241C > T, 1059C > T, 3037C > T, 14408C > T, 23403A > G, 25563G > T
Mutational Profile 10 B.1.1 O 0.287 241C > T, 14408C > T, 23403A > G, 28881G > A, 28882G > A, 28883G > C
Mutational Profile 11 B O 0.287 241C > T, 14408C > T, 23403A > G
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3.4. Spatio-Temporal Mutational Profile Appearances in Swedish SARS-CoV-2 Variants
To further investigate the spatial-temporal appearances of these 11 mutational profiles, we plotted
the accumulated counts for each profile by months and locations (Figure S1). As observed in the Muller
plot, MP3 and MP6 had been outcompeting the other MPs and became the dominant MPs in Sweden,
followed by MP4, MP9, and MP1. MP6 increased significantly after day 40 (March 17) and reached
the second highest of the accumulated mutant accounts. The facet grid multiple plots showed that in
March, nine MPs (all except MP7 and MP11) were circulating in Stockholm. In contrast, MP7 originated
in Värmland, and MP11 originated in Halland. In April, although very few sequences represented
Stockholm due to limited sampling, MP3, MP4, and MP6 were still disseminated in different regions in
Sweden, especially in Uppsala and Västra Götaland (Figure S1).
Further analyses on spatial and infected individual characteristics were made for MP3 and MP6.
The GISAID contains limited metadata for the Swedish sequences, with the maximal information being
patient age, gender, geographic location, and date that the sample was collected. From these limited
data, we compiled metadata plots on MP3 and MP6 (Figure 2). It appears that the age group from 40
to 49 years was the target group for both MP3 and MP6, whilst MP3 also had a preference for the age
group of 10 to 19 years, with a gender bias and distributed in the geographic locations with the order
of highest number in Stockholm (Figure 2).Viruses 2020, 12, x FOR PEER REVIEW 8 of 15 
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3.5. Bayesian Phylogenetic Analysis
Model comparison preferr d a strict molecular clock mode and a coalescent exponential popul tion
demogr phic model for the evolutionary history of Swedish SARS-CoV-2 (Figure 3). The evolutionary
rate for this dataset is 1.5425 × 10−3 substitutions per year (95% highest posteri r density (HPD),
1.2795 × 10−3 to 1.8259 × 0−3; Table S2.). Rapid community tra smission started on the 1 February
(95% HPD, 16 January to 14 February). The emergenc of MP3 and MP6 were on 17 February (95%
HPD, 8 February to 24 February) and 25 February (95% HPD, 14 February to 9 March), respectively.
Phylogenetic analyses showed that almost all different MPs cluster together, except MP10 that fell into
the MP3 cluster, and MP11 that fell into the MP4 cluster. MP4, MP5, MP6, MP8, and MP9 belong to
lineage B.1, while MP2 and MP3 belong to B.1.1.
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4. Discussion
Continuous molecular tracing of SARS-CoV-2 is needed for effective surveillance and interventions.
FHM has been monitoring the molecular traits of Swedish SARS-CoV-2 since the initial cases in Sweden.
Two reports from FHM, not yet published in peer-reviewed journals but available on their web-page
(www.folkhalsomyndigheten.se), indicate that the initial introductions of SARS-CoV-2 to Sweden
originate from Italy and Austria [18,19]. Our study has similar findings to the FHM reports with
independent genotypes circulating, which are highly likely to have originated from independent
geographic locations. However, our study is more focused on the genetic variations among the Swedish
SARS-CoV-2 sequences and the evolutionary events that have occurred.
Most RNA virus populations exist as complex mixtures of genetic and phenotypic variants,
resulting from the high RNA polymerase error rate [20]. The theoretical advantage of maintaining such
a diverse viral population is that a variant might fit into a new environment when the virus spreads.
In certain circumstances, some mutations could be drivers for the emergence of new trains with changed
pathogenicity. For instance, a mutation in the Zika virus membrane region (prM-S139N) emerged
in a viral lineage preceding the devastating epidemic in the Americas [21], while a single mutation
(GP-A82V) in Ebola virus increased the infection rate of human cells [22]. However, coronaviruses
have RDRp and nsP14 proteins with proofreading, and therefore mutations occur at a lower rate as
compared to most other RNA viruses [23]. Still, genetic drift is the main evolutionary mode for Swedish
SARS-CoV-2, and the wide spreading of SARS-CoV-2 have already resulted in different clades/lineages
that differ from the original strain from Wuhan, where the first cases were found (Figure S1). There is
no information available on whether these variants could affect the transmissibility or infectivity
of SARS-CoV-2. The continuous pandemic may enable accumulation of immunologically relevant
mutations in the SARS-CoV-2 genome [24]. Point mutations have been shown to result in resistance to
neutralizing antibodies in MERS-CoV [25] and SARS-CoV [26]. Antigenic drift has been demonstrated
in other CoVs, including the common cold coronaviruses OC43 and 229E, and SARS-CoV [27–30]. Our
findings that D936Y in the S protein is under positive selection is consistent with antigenic drift playing
a role for SARS-CoV-2 as well. The S protein of SARS-CoV-2 is responsible for viral entry into host
cells through the receptor binding domain (RBD). Mutations in the S protein may impact development
of pharmacological interventions and sensitive diagnostic methods. However, the functional change of
this mutation is still unclear. One study using mutant modelling and analysis showed that it could
weaken the post-fusion assembly for the virus [31]. Although the frequency of S936Y is low worldwide,
increased frequency has been observed in Nordic countries: 69% (178/258, the number for mutant’s
appearance/total number of SARS-CoV-2) in Finland, 22% (116/531) in Sweden, and 11% (9/83) in
Norway (data from 3 August, http://covid19.datamonkey.org).
Our study also indicates that SARS-CoV-2 evolves through certain mutational profiles, i.e.,
multiple genes are likely involved in the evolution. A mutated virus must contain multiple mutations
in different genes in order to keep up with stringent evolutionary constraints [32]. Those mutations
that are favoured by natural selection can spread in the population and act as the mutational backbone
for further genetic variants to evolve from. For our study, we set a ≥5% frequency threshold in the
population as the cut-off for the variant sites. We found that the basis mutations, which contain C241T,
C3037T, C14408T, and A23403G, combined with other mutations can be classified into 10 mutational
profiles in Sweden. A23403G is one of the most prominent mutations; it occurs in the S protein at amino
acid residue 614, where Aspartic acid is substituted by Glycine (D614G). The D614G mutant strain is
designated as the “G clade” by GISAID and originated in Europe, and further spread to North America
and Oceania, then Asia [33]. This mutation can increase infectivity of SARS-CoV-2 based on in vitro
experiments [24]. In Sweden, we found that on 14 May, the frequency of D614G on the S1 protein was
94.8% in the population. All MPs with the exception of MP1 had the basic genomic mutation A23403G.
Out of the 10 mutational profiles, MP6 appeared latest within our investigation period and could have
the carrying capacity to outcompete MPs in the population after our time-frame. Cavallo L. et al. found
that the D614G/ D936Y co-occur on the S1/S2 protein, and their emergence was traced back to 15 March
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in Washington, USA, and later on spread to Wales, Iceland, and the Netherlands [31]. This provides
more evidence that multiple mutations can modulate viral transmission, replication efficiency, and
virulence in different regions of the world [34]. Therefore, exploring mutational profiles of sequences
is an important complement to analysing single nucleotide polymorphisms and may be more efficient.
We saw this co-occurrence of D614G/D936Y in our data-set with a frequency of 17.2%, which was the
same frequency as MP6. MP6 has the same mutations as in the findings of Cavallo L. et al., but with the
additional mutations T265I on ORF1ab, Q57H on ORF3, and the four basic mutations (C241T, C3037T,
C14408T, and A23403G). We are unable to ascertain the function of the additional mutations found in
MP6 compared to S1/S2 protein findings: this will require additional characterization.
Due to high viral transmissibility and lack of pre-existing immunity, COVID-19 cases surged
in late February and March, mainly in Stockholm. From our Bayesian phylogenetic method, we
have calculated the emergence of COVID-19 in Sweden and the start of community transmission,
which occurred in Stockholm. We found 1.5425 × 10−3 substitutions per year as the evolutionary rate
of Swedish SARS-CoV-2 by using the formal Bayesian inference. This is similar to earlier reports that
demonstrated 1.12 × 10−3 substitutions per year for SARS-CoV-2 [35,36]. However, substitution rates
may be overestimated, as most mutations are under purifying selection [37]. In addition, this analysis
requires caution due to some uncertainties as a result of small sampling size and model selections
during the estimations. Therefore epidemiological evidences have to be incorporated to the analysis,
to reduce the descriptive conclusions of this study [38]. During the pandemic, there have been frequent
updates for new sequenced isolates with evolving nomenclature systems for SARS-CoV-2 such as
Nextstrain, GISAID, and PANGOLIN. According to the PANGOLIN system [39], lineage B.1 is the
predominant global lineage, which comprises the large Italian outbreak and is also associated with
many outbreaks in Europe [40]. Lineage B.1.1 is the main lineage in Europe and was exported to
several areas of the world [39]. B.1 and B.1.1 are the major lineages in Sweden. To further see if how
these major lineages transmitted into Sweden, the report from FMH compared the single nucleotide
polymorphism (SNP) profiles of Swedish sequences and the sequences from Italy and Austria within
the B.1 and B.1.1. They found a clear link between the sequences from Sweden and Italy within B.1.1.
They also observed similarities between sequences from Sweden and Austria within B.1. However,
unlike the Swedish B.1 isolates, the Austrian sequences had no mutations in the S protein at position
936. One explanation of the result seen by FHM could be that further mutational evolution occurred
in Sweden or another geographical location, or that not enough sequencing in Austria was done
to detect these mutations. Unlike the FMH reports, our mutational profiles systems, on the other
hand, can further distinguish those genetic variances with more precision, as B.1 can be further
divided into MP4, MP5, MP6, MP8, and MP9, while B.1.1 can be further divided into MP2, MP3,
and MP10. This additional information can aid in the assessment of the evolutionary paths that
SARS-CoV-2 virus can take to become the predominant genotypes in the population. From remapping
the mutational profiles involved in our analysis in Figure 3 and Table 2, we can see a clear clustering
pattern that still matches with the PANGOLIN and GISAID classification systems that standardized
SARS-CoV-2 nomenclature. Therefore, the use of mutation profiles can be used in conjunction with
other SARS-CoV-2 nomenclature systems to aid in showing the local sub-populations that occur in a
given location during the SARS-CoV-2 pandemic, such as those presented in our paper.
5. Conclusions
Further molecular surveillance on Swedish SARS-CoV-2 is needed to determine whether the two
mutation patterns MP3 (B.1.1) and MP6 (B.1) will be fixed over time. Importantly, characterizing
viruses with these two major mutational profiles in greater depth may aid in understanding viral
infectivity and transmissibility, and potentially add further treatment prospects for COVID-19 patients
in Sweden and worldwide. Mutational profiling may be an efficient additional tool for SARS-CoV-2
molecular epidemiology within a geographical location.
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